ReBuilder Medical Technologies, Inc. 4th Quarter Sales Increase 100% Exceeding Projections
| ReBuilder Medical Technologies logo. (PRNewsFoto/REBUILDER MEDICAL TECHNOLOGIES)
CHARLES TOWN, WV UNITED STATES | |||
Expected Release of Several MRSA Related Products in our Molluscum Line
in the First Quarter of 2008
CHARLES TOWN, W.Va., Dec. 21 /PRNewswire-FirstCall/ -- ReBuilder
Medical Technologies, Inc. (Pink Sheets: RBRM), developers of state of the
art electronic devices for diabetic peripheral neuropathy, Molluscum
Contagiosum, and MRSA, announces 4th quarter sales projections up 100% over
last year.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )
"We are projecting that sales will have doubled for the 4th quarter
over last year; achieving the $1 million mark in sales for the quarter.
Final sales numbers will be reported in January 2008," said Daena Carter,
CFO of RBRM.
"With the expected release of several MRSA related products in our
Molluscum line in the first quarter of 2008 and the expected release of a
unique peripheral neuropathy diagnostic device in the second quarter of
2008; we expect to continue our pattern of growth," according to David B.
Phillips, Ph.D., CEO of RBRM, and inventor of the company's unique
products.
For more information visit: http://www.rebuildermedical.com,
http://www.molluscum.com.
Safe Harbor: This letter contains certain forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as amended
and Section 21E of the Securities Exchange Act of 1934, as amended, which
are intended to be covered by the safe harbors created thereby. Investors
are cautioned that all forward-looking statements involve risks and
uncertainty, including without limitation, the ability of the Company to
successfully implement its turnaround strategy, changes in costs of raw
materials, labor, and employee benefits, as well as general market
conditions, competition and pricing. Although the Company believes that the
assumptions underlying the forward-looking statements contained herein are
reasonable, any of the assumptions could be inaccurate, and therefore,
there can be no assurance that the forward-looking statements included in
this letter will prove to be accurate. In light of the significant
uncertainties inherent in the forward-looking statements included herein,
the inclusion of such information should not be regarded as representation
by the Company or any other person that the objectives and plans of the
Company will be achieved. In assessing forward-looking statements included
herein, readers are urged to carefully read those statements. When used in
the Annual Report on Form 10-K, the words "estimate," "anticipate,"
"expect," "believe," and similar expressions are intended to be
forward-looking statements.
Contact:
Daena Carter of ReBuilder Medical Technologies, Inc.
+1-304-725-2202
